Trulieve Cannabis (TCNNF) Shares Outstanding (Weighted Average) (2020 - 2026)

Trulieve Cannabis (TCNNF) recorded quarterly Shares Outstanding (Weighted Average) of $192.5 million in Q1 2026, up 0.64% quarter-over-quarter from $191.3 million in Q4 2025, and up 0.74% on a YoY basis from $191.1 million in Q1 2025.

Trulieve Cannabis (TCNNF) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Trulieve Cannabis' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $192.5 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 0.74% year-over-year to $192.5 million; the TTM figure through Mar 2026 stood at $192.5 million (up 0.74% YoY), while the FY2025 annual figure was $191.3 million, up 0.7% from the prior year.
  • Shares Outstanding (Weighted Average) was $192.5 million for Q1 2026 at Trulieve Cannabis, up from $191.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $192.5 million in Q1 2026 to a low of $187.1 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $189.6 million across 5 years, with a median of $189.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) surged 56.02% in 2022, then advanced 0.19% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $188.0 million in 2022, then rose by 0.52% to $189.0 million in 2023, then gained by 0.54% to $190.0 million in 2024, then climbed by 0.7% to $191.3 million in 2025, then gained by 0.64% to $192.5 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $192.5 million (Q1 2026), $191.3 million (Q4 2025), and $191.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 100.50 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn 5.11 Bn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 64.74 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 88.01 Mn
10 Trulieve Cannabis - - 170.08 Mn 192.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 192.54 Mn
Dec 31, 2025 191.32 Mn
Sep 30, 2025 191.20 Mn
Jun 30, 2025 191.20 Mn
Mar 31, 2025 191.13 Mn
Dec 31, 2024 189.99 Mn
Sep 30, 2024 190.00 Mn
Jun 30, 2024 189.91 Mn
Mar 31, 2024 189.49 Mn
Dec 31, 2023 188.97 Mn
Sep 30, 2023 188.96 Mn
Jun 30, 2023 188.98 Mn
Mar 31, 2023 188.90 Mn
Dec 31, 2022 188.00 Mn
Sep 30, 2022 188.60 Mn
Jun 30, 2022 187.17 Mn
Mar 31, 2022 187.05 Mn
Dec 31, 2021 139.37 Mn
Sep 30, 2021 128.15 Mn
Jun 30, 2021 120.35 Mn